The trajectory of Viagra presents a complex picture for shareholders. While the initial release generated massive returns, the end of its exclusive rights opened the floodgates to generic alternatives, dramatically https://bookmarkalexa.com/story7343303/sildenafil-and-big-pharma-a-risky-bet